Publications

  1. Bobo WV, Pathak J, Kremers HM, Yawn BP, Brue SM, Stoppel CJ, Croarkin PE, St Sauver J, Frye MA, Rocca WA. An electronic health record driven algorithm to identify incident antidepressant medication users. J Am Med Inform Assoc. 2014 Sep; 21(5):785-91. Epub 2014 Apr 29.
    View PubMed
  2. Croarkin PE, Nakonezny PA, Husain MM, Port JD, Melton T, Kennard BD, Emslie GJ, Kozel FA, Daskalakis ZJ. Evidence for Pretreatment LICI Deficits Among Depressed Children and Adolescents With Nonresponse to Fluoxetine. Brain Stimul. 2014 Mar-Apr; 7(2):243-51. Epub 2013 Dec 03.
    View PubMed
  3. Croarkin PE, Nakonezny PA, Husain MM, Melton T, Buyukdura JS, Kennard BD, Emslie GJ, Kozel FA, Daskalakis ZJ. Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder. JAMA Psychiatry. 2013 Mar; 70(3):291-9.
    View PubMed
  4. Wall CA, Croarkin PE, McClintock SM, Murphy LL, Bandel LA, Sim LA, Sampson SM. Neurocognitive effects of repetitive transcranial magnetic stimulation in adolescents with major depressive disorder. Front Psychiatry. 2013; 4:165. Epub 2013 Dec 12.
    View PubMed
  5. Tian F, Kozel FA, Yennu A, Croarkin PE, McClintock SM, Mapes KS, Husain MM, Liu H. Test-retest assessment of cortical activation induced by repetitive transcranial magnetic stimulation with brain atlas-guided optical topography. J Biomed Opt. 2012 Nov; 17(11):116020.
    View PubMed
  6. Wall CA, Croarkin PE, Swintak C, Koplin BA. Psychiatric pharmacogenomics in pediatric psychopharmacology. Child Adolesc Psychiatr Clin N Am. 2012 Oct; 21(4):773-88.
    View PubMed
  7. Emslie GJ, Kennard BD, Mayes TL, Nakonezny PA, Zhu L, Tao R, Hughes C, Croarkin P. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth. J Child Adolesc Psychopharmacol. 2012 Feb; 22(1):21-8. Epub 2012 Jan 18.
    View PubMed
  8. Croarkin PE, Wall CA, Nakonezny PA, Buyukdura JS, Husain MM, Sampson SM, Emslie GJ, Kozel FA. Increased cortical excitability with prefrontal high-frequency repetitive transcranial magnetic stimulation in adolescents with treatment-resistant major depressive disorder. J Child Adolesc Psychopharmacol. 2012 Feb; 22(1):56-64. Epub 2012 Jan 18.
    View PubMed
  9. Croarkin PE, Nakonezny PA, Husain MM, Melton T, Buyukdura JS, Kennard BD, Emslie GJ, Kozel FA. Evidence for Increased Glutamatergic Cortical Facilitation in Children and Adolescents With Major Depressive Disorder Arch Gen Psychiatry (in press). 2012.
  10. Coarkin PE, Wall CA, King JD, Andrew Kozel F, Daskalakis ZJ. Pain during transcranial magnetic stimulation in youth. Innov Clin Neurosci. 2011 Dec; 8(12):18-23.
    View PubMed
  11. Croarkin PE, Wall CA, Lee J. Applications of transcranial magnetic stimulation (TMS) in child and adolescent psychiatry. Int Rev Psychiatry. 2011 Oct; 23(5):445-53.
    View PubMed
  12. Wall CA, Croarkin PE, Sim LA, Husain MM, Janicak PG, Kozel FA, Emslie GJ, Dowd SM, Sampson SM. Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. J Clin Psychiatry. 2011 Sep; 72(9):1263-9.
    View PubMed
  13. Buyukdura JS, McClintock SM, Croarkin PE. Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30; 35(2):395-409. Epub 2010 Oct 31.
    View PubMed
  14. Croarkin PE, Levinson AJ, Daskalakis ZJ. Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci Biobehav Rev. 2011 Jan; 35(3):818-25. Epub 2010 Oct 12.
    View PubMed
  15. Kozel FA, Rao U, Lu H, Nakonezny PA, Grannemann B, McGregor T, Croarkin PE, Mapes KS, Tamminga CA, Trivedi MH. Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder. Front Psychiatry. 2011; 2:7. Epub 2011 Mar 08.
    View PubMed
  16. Croarkin PE, Wall CA, McClintock SM, Kozel FA, Husain MM, Sampson SM. The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. J ECT. 2010 Dec; 26(4):323-9.
    View PubMed
  17. Elmquist JM, Melton TK, Croarkin P, McClintock SM. A systematic overview of measurement-based care in the treatment of childhood and adolescent depression. J Psychiatr Pract. 2010 Jul; 16(4):217-34.
    View PubMed
  18. Khan AA, Strawn JR, Croarkin PE. Emerging Treatment Options in Bipolar Disorder in Adolescents: Focus on Ziprasidone. Adolescent Health Medicine and Therapeutics. 2010; 1:137-143.
  19. Kozel FA, Tian F, Dhamne S, Croarkin PE, McClintock SM, Elliott A, Mapes KS, Husain MM, Liu H. Using simultaneous repetitive Transcranial Magnetic Stimulation/functional Near Infrared Spectroscopy (rTMS/fNIRS) to measure brain activation and connectivity. Neuroimage. 2009 Oct 1; 47(4):1177-84. Epub 2009 May 14.
    View PubMed
  20. Croarkin PE, McCaffrey PC, McClintock SM, Rodez C, Husain MM. Electroconvulsive Therapy in Child and Adolescent Psychiatry. Current Psychiatry Reviews 5(4):. 2009; Current Psychiatry Reviews 2009:298-305.
  21. Croarkin PE, Emslie GJ, Mayes TL. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. J Clin Psychiatry. 2008 Jul; 69(7):1157-65.
    View PubMed
  22. Yanofski J, Croarkin P. Choosing Antidepressants for HIV and AIDS Patients: Insights on Safety and Side Effects. Psychiatry (Edgmont). 2008 May; 5(5):61-6.
    View PubMed
  23. Croarkin P, Berg J, Spira J. Informed consent for psychotherapy: a look at therapists' understanding, opinions, and practices. Am J Psychother. 2003; 57(3):384-400.
    View PubMed
  24. Croarkin P. From King George to neuroglobin: the psychiatric aspects of acute intermittent porphyria. J Psychiatr Pract. 2002 Nov; 8(6):398-405.
    View PubMed